|
WO2005058315A1
|
|
Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
|
|
WO2004065398A2
|
|
Synthesis and use of 2'-substituted-n6-modified nucleosides
|
|
AU2003225705A1
|
|
Cytidine analogs and methods of use
|
|
ZA200300649B
|
|
Methods of drug delivery to hepatocytes and treatment of flaviviridae infections.
|
|
ZA200300618B
|
|
Improved specificity in treatment of diseases.
|
|
US6906190B2
|
|
Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
|
|
WO2004061409A2
|
|
Parallel inducible cell-based kinase screen
|
|
AU2002353164A1
|
|
Unusual nucleoside libraries, compounds, and preferred uses as antiviral and anticancer agents
|
|
AU2002357876A1
|
|
Nucleoside analog libraries and compounds
|
|
AU2002359732A1
|
|
Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
|
|
AU2002353165A1
|
|
Deazapurine nucleoside libraries and compounds
|
|
US6815542B2
|
|
Nucleoside compounds and uses thereof
|
|
WO03051896A1
|
|
Cytidine libraries and compounds synthesized by solid-phase combinatorial strategies
|
|
WO03037908A1
|
|
Antiviral combination therapy and compositions
|
|
WO03052053A2
|
|
Nucleoside libraries and compounds by mcc combinatorial strategies on solid support
|
|
WO03062256A1
|
|
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
|
WO03061385A1
|
|
Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents
|
|
ZA200207336B
|
|
Antiviral prodrugs.
|
|
AU2002368154A1
|
|
Improved synthesis for hydroxyalkylated heterocyclic bases
|
|
US6833361B2
|
|
Nucleosides having bicyclic sugar moiety
|
